RIG
VRTX icon

Roosevelt Investment Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Roosevelt Investment Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$29.2M Buy
100,744
+1,500
+2% +$432K 2.1% 8
2022
Q2 		$28M Sell
99,244
-835
-0.8% -$223K 2.01% 9
2022
Q1 		$26.1M Buy
100,079
+2,939
+3% +$698K 1.56% 19
2021
Q4 		$21.3M Buy
97,140
+1,673
+2% +$325K 1.18% 33
2021
Q3 		$17.3M Sell
95,467
-1,545
-2% -$302K 1.07% 37
2021
Q2 		$19.6M Buy
97,012
+38,903
+67% +$8.14M 1.18% 35
2021
Q1 		$12.5M Sell
58,109
-1,587
-3% -$349K 0.82% 45
2020
Q4 		$14.1M Buy
59,696
+2,053
+4% +$471K 1% 41
2020
Q3 		$15.7M Buy
57,643
+1,069
+2% +$295K 1.27% 34
2020
Q2 		$16.4M Sell
56,574
-23,336
-29% -$6.33M 1.62% 23
2020
Q1 		$19M Buy
79,910
+1,009
+1% +$231K 2.18% 15
2019
Q4 		$17.3M Buy
78,901
+174
+0.2% +$35.2K 1.78% 26
2019
Q3 		$13.3M Buy
78,727
+873
+1% +$154K 1.52% 35
2019
Q2 		$14.3M Buy
77,854
+10,060
+15% +$1.76M 1.67% 27
2019
Q1 		$12.5M Buy
67,794
+13,439
+25% +$2.48M 1.55% 29
2018
Q4 		$9.01M Buy
+54,355
New +$9.42M 0.99% 38

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Roosevelt Investment Group's VRTX Position: Q3 2022 in Review

Roosevelt Investment Group increased its Vertex Pharmaceuticals (VRTX) stake by 1.5% in Q3 2022, buying an estimated $432K and bringing the position to 100,744 shares worth $29.2M. The position accounts for 2.1% of the portfolio, ranked #8.

Roosevelt Investment Group first reported a position in VRTX in Q4 2018 and has held it in 16 quarters since. 1,124 funds tracked by Wall St. Rank hold VRTX as of Q3 2022.

  • Roosevelt Investment Group held 100,744 shares of Vertex Pharmaceuticals worth $29.2M as of Q3 2022.
  • Roosevelt Investment Group bought 1,500 Vertex Pharmaceuticals shares in Q3 2022, an estimated $432K.
  • Vertex Pharmaceuticals made up 2.1% of Roosevelt Investment Group's portfolio in Q3 2022, its #8 holding.
  • Roosevelt Investment Group first reported a position in Vertex Pharmaceuticals in Q4 2018 and has held it in 16 quarters since.
  • 1,124 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2022.

Based on Roosevelt Investment Group's 13F filing for Q3 2022, filed 19 Oct 2022.